Literature DB >> 5944408

A prognostic study of juvenile rheumatoid arthritis. Analysis of 544 cases.

A L Laaksonen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5944408

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


× No keyword cloud information.
  7 in total

1.  An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood.

Authors:  Clive Edelsten; Vickie Lee; Christopher R Bentley; Jack J Kanski; Elizabeth M Graham
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Juvenile chronic arthritis: spectrum of disease in an adult rheumatology department.

Authors:  O FitzGerald; B Bresnihan
Journal:  Ir J Med Sci       Date:  1986-08       Impact factor: 1.568

3.  Rheumatoid arthritis and growth retardation in children: treatment with human growth hormone.

Authors:  O Butenandt
Journal:  Eur J Pediatr       Date:  1979-01-18       Impact factor: 3.183

4.  Articular damage in adults with juvenile idiopathic arthritis.

Authors:  Eda Gurcay; Emel Eksioglu; Serdil Yuzer; Ajda Bal; Aytul Cakci
Journal:  Rheumatol Int       Date:  2008-10-14       Impact factor: 2.631

5.  Rheumatoid arthritis during the first year of life. A case report and review of the literature.

Authors:  N Gadoth; Y Hershkovitch
Journal:  Eur J Pediatr       Date:  1979-10       Impact factor: 3.183

6.  Prevalence of juvenile idiopathic arthritis in Sharkia Governorate, Egypt: epidemiological study.

Authors:  Amany M Abou El-Soud; Amany R El-Najjar; Eman E El-Shahawy; Hanan A Amar; Tamer H Hassan; Somia H Abd-Allaha; Hosnia M Ragab
Journal:  Rheumatol Int       Date:  2013-03-20       Impact factor: 2.631

Review 7.  Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions.

Authors:  Katherine Anne B Marzan
Journal:  Adolesc Health Med Ther       Date:  2012-06-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.